- Science: Smoking of cannabis does not increase risk for oral cancer
- News in brief
- A glimpse @ the past
Contrary to previous research findings cannabis smoking does not appear to be associated with an increased risk of developing oral cancer, according to a large study from the USA. The results appeared in the June issue of Cancer Research. The study of Dr. Karin A. Rosenblatt and colleagues found no association between cannabis use and increased oral-cancer risk, regardless of how long, how much or how often a person has used cannabis.
"When asking whether any marijuana use puts you at increased risk of oral cancer, our study is pretty solid in saying there's nothing going on there," said Dr. Stephen M. Schwartz, one of the authors of the study. But because the incidence of extensive, long-term cannabis use was low among the study population it is unclear whether extremely heavy use over many years is related to the risk for oral cancer, Schwartz said. The study involved 407 oral-cancer cases and 615 healthy control subjects from the state of Washington who had been interviewed in detail about their history of marijuana use, among other lifestyle factors. Participants ranged in age from 18 to 65.
The new study counters findings from a smaller investigation with 173 oral cancer patients, published in 1999, which suggested that ever-users of marijuana were at more than twice the risk of getting head-and-neck cancer as compared to non-users. The earlier study had a number of limitations, most importantly the fact that its control, or comparison, group was comprised of individuals who had donated blood at the same hospital where the oral-cancer cases had been treated. Blood donors tend to have fewer high-risk habits than the general population.
(Sources: Rosenblatt KA, et al. Marijuana use and risk of oral squamous cell carcinoma. Cancer Res 2004;64:4049-54. Press release of the Fred Hutchinson Cancer Research Center of 1 June 2004)
Ordered by the Dutch health ministry Pharmo Instituut interviewed 200 patients, who receive medical cannabis from the pharmacies. Two third were females. 71 per cent of participants were between 40 an 70 years of age. The most frequent indications were chronic pain (72.5 per cent) and spasticity (53.0 per cent). 42 per cent suffered from multiple sclerosis and 11 per cent from arthritis. 40 per cent could reduce their other medical drugs through their cannabis use. (Source: Pharmo Instituut. Medicinale gebruik van cannabis. April 2004; Press release of the Pharmo Instituut of 2. June 2004)
Canada: Medical cannabis
Canada Post has been refusing to deliver medicinal marijuana to licensed users and it is unclear whether they will agree to change their policy. The post office is sticking to a regulation that treats any kind of marijuana shipment as prohibited. (Source: Globe and Mail of 4 June 2004)
Canada: Raid in cannabis centre
On 27 May the police seized cannabis plants from the Vancouver Island Compassion Society. This means 390 ill people will now have to rely on the black market for their supply, said Phillippe Lucas, president of the centre. Officers arrested two men, who face charges of growing and trafficking of marijuana. (Source: Victoria Times-Colonist of 30 May 2004)
One year ago
- Science: THC reduces agitation and improves appetite in Alzheimer's patients
- USA: Ed Rosenthal sentenced to one day in prison
Two years ago
Uruguay: Course on Cannabis in Medicine.
USA: Cannabis Quality, 19-21 July 2016, Los Angeles.
France: Conference of the UFCM, 21 October 2016, Strasbourg.
Switzerland: Conference of the SACM 2016, 12 November 2016, Bern.
Israel: The International Medical Cannabis Conference, 11-13 September, 2016
The Cannabinoid Conference 2017 of the IACM, 29-30 September 2017, Cologne, Germany.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.